Biophysics Seminar

Is radiotherapy fading? (Hybrid seminar)

by Prof. Marco Durante (GSI Helmholtzzentrum für Schwerionenforschung GmbH)

Europe/Berlin
Lecture hall, Theory SB3 3.170a and https://gsi-fair.zoom.us/j/68032300494; Passcode: BIO

Lecture hall, Theory SB3 3.170a and https://gsi-fair.zoom.us/j/68032300494; Passcode: BIO

Hybrid-Biophysics seminar
Description

Abstract

Radiotherapy is commonly used in adjuvant or neo-adjuvant settings in several tumor pathologies. Recent clinical trials, however, have shown that adjuvant radiotherapy does not provide additional benefit but only increases toxicity. These results include common cancers such as breast, thyroid or colon cancer. We will discuss these data and will argue that these observations can represent an opportunity for strengthen the case for particle therapy, owing to its reduced toxicity and potential improvements in combined therapy. 

Organized by

Prof. Dr. Marco Durante